- Home
- FXNC vs SCPH Comparison
FXNC vs SCPH Comparison
Compare FXNC & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FXNC
- SCPH
- Stock Information
- Founded
- FXNC 1907
- SCPH 2013
- Country
- FXNC United States
- SCPH United States
- Employees
- FXNC N/A
- SCPH N/A
- Industry
- FXNC Major Banks
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- FXNC Finance
- SCPH Health Care
- Exchange
- FXNC Nasdaq
- SCPH Nasdaq
- Market Cap
- FXNC 201.9M
- SCPH 173.6M
- IPO Year
- FXNC N/A
- SCPH 2017
- Fundamental
- Price
- FXNC $18.60
- SCPH $2.57
- Analyst Decision
- FXNC Strong Buy
- SCPH Strong Buy
- Analyst Count
- FXNC 1
- SCPH 3
- Target Price
- FXNC $21.00
- SCPH $14.00
- AVG Volume (30 Days)
- FXNC 22.1K
- SCPH 519.0K
- Earning Date
- FXNC 04-29-2025
- SCPH 05-13-2025
- Dividend Yield
- FXNC 3.32%
- SCPH N/A
- EPS Growth
- FXNC N/A
- SCPH N/A
- EPS
- FXNC 1.00
- SCPH N/A
- Revenue
- FXNC $58,014,000.00
- SCPH $36,332,000.00
- Revenue This Year
- FXNC $57.36
- SCPH $114.00
- Revenue Next Year
- FXNC $4.25
- SCPH $77.45
- P/E Ratio
- FXNC $18.60
- SCPH N/A
- Revenue Growth
- FXNC 18.28
- SCPH 167.28
- 52 Week Low
- FXNC $14.50
- SCPH $1.94
- 52 Week High
- FXNC $26.97
- SCPH $5.65
- Technical
- Relative Strength Index (RSI)
- FXNC 24.00
- SCPH 47.35
- Support Level
- FXNC $18.50
- SCPH $1.94
- Resistance Level
- FXNC $21.00
- SCPH $2.71
- Average True Range (ATR)
- FXNC 0.85
- SCPH 0.27
- MACD
- FXNC -0.16
- SCPH 0.04
- Stochastic Oscillator
- FXNC 2.38
- SCPH 76.36
About FXNC First National Corporation
First National Corp is a bank holding company of First Bank, which is a commercial bank. Its core offering includes loans, deposits, wealth management, and other products and services. Loan products and services include personal loans, residential mortgages, home equity loans, and commercial loans. Deposit products and services include checking and savings. The Bank's wealth management division offers estate planning, investment management of assets, retirement accounts, and estate settlement.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.